In this cross-sectional study, 286 adults and 513 caregivers of children with symptomatic AR of at least moderate severity who are currently or have previously received allergy immunotherapy (AIT) entered the questionnaire. We excluded respondents who partly completed the survey, who are receiving or have received AIT using a sublingual or an unknown route, or who stopped AIT more than five years earlier....